Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics
Expansion follows summer 2025 $30 million equity round led by WestRiver Group SEATTLE, Oct. 8, 2025 /PRNewswire/ — Lumen Bioscience—a clinical-stage biotech developing orally delivered biologics—today announced key leadership enhancements. Continue Reading WestRiver Group is a thematically‑driven investment platform that manages funds and builds companies in the global innovation economy. Backed by some of the world’s […]
Boston-Based Newforma Joins Forces with the Boston Bruins and TD Garden
BOSTON, Oct. 8, 2025 /PRNewswire/ — Newforma, the market leader in project and information management for the architecture, engineering, construction and owner (AECO) industry, today announced a multi-year partnership with the Boston Bruins and TD Garden. As a “Proud Partner of the Boston Bruins & TD Garden,” the Boston-headquartered technology company is championing its hometown […]
WESTERN MIDSTREAM AND ARIS WATER SOLUTIONS ANNOUNCE PRELIMINARY RESULTS FOR ELECTION OF FORM OF MERGER CONSIDERATION
HOUSTON, Oct. 8, 2025 /PRNewswire/ — Western Midstream Partners, LP (NYSE: WES) (“WES”) and Aris Water Solutions, Inc. (NYSE: ARIS) (“Aris”) jointly announced today the preliminary results of the elections made by Aris securityholders regarding the form of merger consideration (the “Merger Consideration”) to be received in connection with WES’s pending acquisition of Aris (the “Transaction”). […]
Eventus launches Frank AI, new technology purpose-built for financial compliance, surveillance analytics
Deterministic AI approach brings secure, repeatable, transparent results critical to regulatory compliance AUSTIN, Texas, Oct. 8, 2025 /PRNewswire/ — Eventus, a leading provider of comprehensive, at-scale trade surveillance and financial risk solutions, today announced the launch of Frank AI, its artificial intelligence solution purpose-built for financial compliance teams and surveillance analytics. Eventus’ use of deterministic AI […]
Highmark Health Appoints Karen Hanlon President
David Holmberg continues as Highmark Health Chief Executive Officer and Highmark Inc. Board Chairman PITTSBURGH, Oct. 8, 2025 /PRNewswire/ — Highmark Health announced today that its Board of Directors has appointed Karen Hanlon president of Highmark Health effective immediately. Hanlon will also retain her current title of chief operating officer and will continue to report […]
Home State Health Launches First Foster Care Center of Excellence in Partnership with Jordan Valley Community Health Center
ST. LOUIS, Oct. 8, 2025 /PRNewswire/ — Home State Health is proud to announce its first Foster Care Center of Excellence (FCCoE), in collaboration with Jordan Valley Community Health Center, marking a significant milestone in the organization’s commitment to improving the health outcomes and well-being of children and youth in Missouri’s foster care system. This […]
Stepan to Announce Third Quarter 2025 Results on October 29, 2025
NORTHBROOK, Ill., Oct. 8, 2025 /PRNewswire/ — Stepan Company (NYSE: SCL) will issue its third quarter 2025 earnings results on Wednesday, October 29, 2025 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss […]
Waterlily Launches “Quote-and-Apply” to Simplify Long-Term Care Insurance Shopping
AI-powered platform lets families and advisors compare policies and apply for coverage within minutes SAN FRANCISCO, Oct. 8, 2025 /PRNewswire/ — Waterlily, which uses AI to predict long-term care (LTC) needs up to decades before they happen, announced today the launch of Quote-and-Apply. This new offering uses AI and brute force computation across hundreds of […]
Vivace Therapeutics’ VT3989 Granted Fast Track Designation by the U.S. Food and Drug Administration for the Treatment of Mesothelioma
SAN MATEO, Calif., Oct. 8, 2025 /PRNewswire/ — Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class cancer therapies targeting the Hippo pathway, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to VT3989, the company’s first-in-class and best-in-class transcriptional enhanced associate domain (TEAD) autopalmitoylation inhibitor. […]
Industry Veteran David Dubrof Joins Rising Medical Solutions as Chief Growth Officer
CHICAGO, Oct. 8, 2025 /PRNewswire/ — Rising Medical Solutions (Rising) is pleased to announce the appointment of David Dubrof as Chief Growth Officer. A seasoned executive with more than 30 years of leadership experience in the workers’ compensation, healthcare, and technology sectors, David will spearhead Rising’s client acquisition and retention strategies, drive market expansion, and […]